178 related articles for article (PubMed ID: 1958854)
1. Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo.
Kikuchi Y; Sasa H; Kita T; Hirata J; Tode T; Nagata I
Anticancer Drugs; 1991 Feb; 2(1):63-7. PubMed ID: 1958854
[TBL] [Abstract][Full Text] [Related]
2. [In vitro and in vivo effects of ginsenoside Rh2 on the proliferation of serous cystadenocarcinoma of the human ovary].
Tode T; Kikuchi Y; Sasa H; Hirata J; Kita T; Imaizumi E; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):589-94. PubMed ID: 1619319
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effects of oral administration of ginsenoside Rh2 on tumor growth in nude mice bearing serous cyst adenocarcinoma of the human ovary].
Tode T; Kikuchi Y; Hirata J; Kita T; Imaizumi E; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1275-82. PubMed ID: 8258727
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice.
Tode T; Kikuchi Y; Kita T; Hirata J; Imaizumi E; Nagata I
J Cancer Res Clin Oncol; 1993; 120(1-2):24-6. PubMed ID: 8270603
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.
Nakata H; Kikuchi Y; Tode T; Hirata J; Kita T; Ishii K; Kudoh K; Nagata I; Shinomiya N
Jpn J Cancer Res; 1998 Jul; 89(7):733-40. PubMed ID: 9738980
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant effects of antineoplastic prostaglandins to cisplatin in nude mice bearing human ovarian cancer cells.
Kikuchi Y; Kita T; Miyauchi M; Hirata J; Sasa H; Nagata I; Fukushima M
J Cancer Res Clin Oncol; 1992; 118(6):453-7. PubMed ID: 1618893
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma].
Kikuchi Y; Miyauchi M; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):121-8. PubMed ID: 2313142
[TBL] [Abstract][Full Text] [Related]
8. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation.
Kikuchi Y; Kizawa I; Oomori K; Miyauchi M; Kita T; Sugita M; Tenjin Y; Kato K
Cancer Res; 1987 Jan; 47(2):592-6. PubMed ID: 3791243
[TBL] [Abstract][Full Text] [Related]
10. [Differentiation of B16 melanoma cells induced by ginsenoside RH2].
Xia LJ; Han R
Yao Xue Xue Bao; 1996; 31(10):742-5. PubMed ID: 9863241
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside-Rh1 and Rh2 inhibit the induction of nitric oxide synthesis in murine peritoneal macrophages.
Park YC; Lee CH; Kang HS; Kim KW; Chung HT; Kim HD
Biochem Mol Biol Int; 1996 Nov; 40(4):751-7. PubMed ID: 8950033
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
Oh M; Choi YH; Choi S; Chung H; Kim K; Kim SI; Kim DK; Kim ND
Int J Oncol; 1999 May; 14(5):869-75. PubMed ID: 10200336
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities.
Bae EA; Han MJ; Choo MK; Park SY; Kim DH
Biol Pharm Bull; 2002 Jan; 25(1):58-63. PubMed ID: 11824558
[TBL] [Abstract][Full Text] [Related]
14. Sensitisation of human ovarian carcinoma cells to cis-diamminedichloroplatinum (II) by amphotericin B in vitro and in vivo.
Kojima M; Kikkawa F; Oguchi H; Mizuno K; Maeda O; Tamakoshi K; Ishikawa H; Kawai M; Suganuma N; Tomoda Y
Eur J Cancer; 1994; 30A(6):773-8. PubMed ID: 7917536
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
[TBL] [Abstract][Full Text] [Related]
16. Effects of granulocyte-colony-stimulating factor and interleukin-2 on ascites formation and the survival time of nude mice bearing human ovarian cancer cells.
Kikuchi Y; Imaizumi E; Kataoka Y; Hirata J; Kita T; Tode T; Nagata I
Cancer Immunol Immunother; 1996 Dec; 43(5):257-61. PubMed ID: 9024501
[TBL] [Abstract][Full Text] [Related]
17. G1 phase-specific suppression of the Cdk2 activity by ginsenoside Rh2 in cultured murine cells.
Ota T; Maeda M; Odashima S; Ninomiya-Tsuji J; Tatsuka M
Life Sci; 1997; 60(2):PL39-44. PubMed ID: 9000124
[TBL] [Abstract][Full Text] [Related]
18. Growth-inhibitory effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HCl combined with cisplatin on human ovarian cancer cells inoculated into nude mice.
Hiramatsu H; Kikuchi Y; Kudoh K; Kita T; Tode T; Nagata I
Jpn J Cancer Res; 1997 Oct; 88(10):1003-8. PubMed ID: 9414663
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Chen W; Qiu Y
Cell Biochem Biophys; 2015 Jun; 72(2):325-31. PubMed ID: 25561284
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a human ovarian carcinoma cell line: UCI 101.
Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
